Bladder cancer: current optimal intravesical treatment.

  • Lamm D
  • McGee W
  • Hale K
  • 20

    Readers

    Mendeley users who have this article in their library.
  • 23

    Citations

    Citations of this article.

Abstract

Superficial bladder cancer can be treated surgically, but patients are at high risk for recurrence. Tumors are categorized as low, intermediate, and high-risk based on grade, stage, and pattern of recurrence. Low-risk tumors are best treated with a single instillation of chemotherapy (thiotepa, doxorubicin, or mitomycin) (Lamm, 2002). Though effective, the toxicity of bacillus Calmette-Guerin immunotherapy (BCG) restricts its use to treat higher-grade tumors. Intermediate risk tumors can be treated with chemotherapy as well, but will often require immunotherapy. High-risk tumors are best treated with intravesical BCG using a 3-week maintenance schedule. Side effects of BCG immunotherapy can be decreased by logarithmic reductions in dose. Patients who fail BCG may be rescued with BCG plus interferon alfa or radical cystectomy.

Author-supplied keywords

  • Adjuvants, Immunologic
  • Adjuvants, Immunologic: administration & dosage
  • Adjuvants, Immunologic: adverse effects
  • Administration, Intravesical
  • Antineoplastic Agents
  • Antineoplastic Agents: administration & dosage
  • Antineoplastic Agents: adverse effects
  • BCG Vaccine
  • BCG Vaccine: administration & dosage
  • BCG Vaccine: adverse effects
  • Cystectomy
  • Doxorubicin
  • Doxorubicin: administration & dosage
  • Doxorubicin: analogs & derivatives
  • Drug Administration Schedule
  • Epirubicin
  • Epirubicin: administration & dosage
  • Humans
  • Interferon-alpha
  • Interferon-alpha: administration & dosage
  • Mitomycin
  • Mitomycin: administration & dosage
  • Neoplasm Recurrence, Local
  • Neoplasm Recurrence, Local: prevention & control
  • Nurse's Role
  • Patient Selection
  • Risk Factors
  • Salvage Therapy
  • Salvage Therapy: methods
  • Survival Rate
  • Thiotepa
  • Thiotepa: administration & dosage
  • Treatment Failure
  • United States
  • United States: epidemiology
  • Urinary Bladder Neoplasms
  • Urinary Bladder Neoplasms: diagnosis
  • Urinary Bladder Neoplasms: drug therapy
  • Urinary Bladder Neoplasms: epidemiology
  • Urinary Bladder Neoplasms: nursing

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • SGR: 33644846284
  • PUI: 41862517
  • SCOPUS: 2-s2.0-33644846284
  • ISBN: 1053-816X
  • ISSN: 1053-816X
  • PMID: 16294610

Authors

  • Donald L Lamm

  • William R McGee

  • Kaye Hale

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free